StonvexLoading…
StonvexStonvexStonvexCore line items from NXDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $85.97M | $83.22M | $63.28M | $55.13M |
Operating Income | $-1.38M | $-4.15M | $11.58M | $30.77M |
Net Income | $-130.19M | $-51.35M | $-121.86M | $-81.57M |
EPS (Diluted) | $-2.81 | $-1.28 | $-3.26 | $-2.26 |
Total Assets | $1.07B | $1.22B | $1.10B | $1.22B |
Total Liabilities | $353.87M | $391.30M | $213.26M | $205.07M |
Cash & Equivalents | $8.17M | $8.79M | $20.61M | $13.36M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 50.13M | 42.68M | 38.39M | 37.17M |